Authors
Loading...
Analysis shows CD39+ T cells are linked to T cell exhaustion and worse outcomes in AML, suggesting a potential immunotherapeutic target.
Joon Seong Park (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: